Logo image
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9
Journal article   Open access   Peer reviewed

A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9

Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, Michael H Tomasson, Ema Anastasiadou, Kathleen Lindahl, Shaoguang Li, Richard A Van Etten, Julian Borrow, David Housman, …
Proceedings of the National Academy of Sciences - PNAS, Vol.99(11), pp.7622-7627
05/28/2002
DOI: 10.1073/pnas.102583199
PMCID: PMC124303
PMID: 12032333
url
https://doi.org/10.1073/pnas.102583199View
Published (Version of record) Open Access

Abstract

Constitutive activation of tyrosine kinases, such as the BCR/ABL fusion associated with t(9;22)(q34;q22), is a hallmark of chronic myeloid leukemia (CML) syndromes in humans. Expression of BCR/ABL is both necessary and sufficient to cause a chronic myeloproliferative syndrome in murine bone marrow transplantation models, and absolutely depends on kinase activity. Progression of CML to acute leukemia (blast crisis) in humans has been associated with acquisition of secondary chromosomal translocations, including the t(7;11)(p15;p15) resulting in the NUP98/HOXA9 fusion protein. We demonstrate that BCR/ABL cooperates with NUP98/HOXA9 to cause blast crisis in a murine model. The phenotype depends both on expression of BCR/ABL and NUP98/HOXA9, but tumors retain sensitivity to the ABL inhibitor STI571 in vitro and in vivo. This paradigm is applicable to other constitutively activated tyrosine kinases such as TEL/PDGFbetaR. These experiments document cooperative effects between constitutively activated tyrosine kinases, which confer proliferative and survival properties to hematopoietic cells, with mutations that impair differentiation, such as the NUP98/HOXA9, giving rise to the acute myeloid leukemia (AML) phenotype. Furthermore, these data indicate that despite acquisition of additional mutations, CML blast crisis cells retain their dependence on BCR/ABL for proliferation and survival.
Green Fluorescent Proteins Blast Crisis - pathology Humans Bone Marrow Cells - pathology Pyrimidines - pharmacology Imatinib Mesylate Piperazines - pharmacology Disease Progression Homeodomain Proteins - genetics Nuclear Pore Complex Proteins - genetics Fusion Proteins, bcr-abl - genetics Animals Proviruses - genetics Oncogene Proteins, Fusion - genetics Cell Division Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology Bone Marrow Transplantation Cloning, Molecular Luminescent Proteins - genetics Antineoplastic Agents - pharmacology Mice Benzamides Tumor Cells, Cultured Disease Models, Animal

Details

Logo image